mtDNA disease in the primary care setting

Archives of Internal Medicine

Volumn 161, Issue 20, 2001, Pages 2497-2500

  Spellberg, Brad ^a   Carroll, R Matt ^a   Robinson, Edmondo ^b   Brass, Eric ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Sigma Tau Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; IDEBENONE; MITOCHONDRIAL DNA; NICOTINAMIDE; THIAMINE; UBIQUINONE;

ADULT; AEROBIC METABOLISM; ARTICLE; CASE REPORT; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; PEDIGREE; PERCEPTION DEAFNESS; POINT MUTATION; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE;

EID: 0035851315     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.20.2497     Document Type: Article

References (61)

1. Prevalence of Japanese dialysis patients with an Ato-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene
2. High prevalence of mitochondrial diabetes mellitus in Japanese patients with major risk factors
3. Prevalence and clinical characterization of Japanese diabetes mellitus with an A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene
4. Prevalence of mitochondrial gene mutations among hearing impaired patients
5. Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia
6. Extraocular muscle biopsy in chronic progressive external ophthalmoplegia
7. Mitochondrial myopathy with lactic acidosis and deficient activity of muscle succinate cytochrome c-oxidoreductase
8. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome
9. A mitochondrial encephalomyopathy: The first case with an established defect at the level of coenzyme Q
10. Longterm coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: A 31P NMR study
11. Maternal inheritance of human mitochondrial DNA
12. Mitochondrial encephalomyopathies
13. Oxidative phosphorylation defect in the brains of carriers of the tRNAleu (UUR) A3243G mutation in a MELAS pedigree
14. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy
15. Differential occurrence of mutations in mitochondrial DNA of human skeletal muscle during aging
16. Mitochondrial inheritance in a mitochondrially mediated disease
17. Maternally inherited mitochondrial myopathy and myoclonic epilepsy
18. Heterogeneous phenotypes of mitochondrial encephalomyopathy in a single kindred
19. Familial mitochondrial encephalomyopathy with strokelike episodes and episodic disturbances of consciousness: A study of pedigree including three generations with multisystemic abnormalities
20. Pancreatic exocrine dysfunction associated with mitochondrialtRNA(Leu)(UUR) mutation
21. Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion
22. Optic neuropathy associated with mitochondrial tRNA[Leu(UUR)] A3243G mutation
23. Pigmentary retinopathy associated with the mitochondrial DNA 3243 point mutation
24. Peripheral neuropathy in mitochondrial encephalomyopathies
25. Diabetes mellitus associated with the 3243 mitochondrial tRNA(Leu)(UUR) mutation: Insulin secretion and sensitivity
26. Cardiac involvement in mitochondrial diseases: A study of 17 patients with documented mitochondrial DNA defects
27. Follow-up in carriers of the 'MELAS' mutation without strokes
28. Acute renal failure and the MELAS syndrome: A mitochondrial encephalomyopathy
29. Hereditary glomerulopathy associated with a mitochondrial tRNA (Leu) gene mutation
30. A case of late-onset MELAS
31. Mitochondrial encephalopathies: Molecular genetic diagnosis from blood samples
32. Contrasting histochemical features of various mitochondrial syndromes
33. Monozygotic twins with MELAS-like syndrome lacking ragged red fibers and lactacidaemia
34. A mitochondrial encephalomyopathy with cardiomyopathy: A case revealing a defect of complex I in the respiratory chain
35. Deficiency of subunits of complex I and mitochondrial encephalomyopathy
36. Findings in muscle in complex I (NADH coenzyme (Q reductase) deficiency
37. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation
38. A mutation in the tRNA (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies
39. Quantification of tRNA3243(Leu) point mutation of mitochondrial DNA in MELAS patients and its effects on mitochondrial transcription
40. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population
41. MELAS: Clinical features, biochemistry, and molecular genetics
42. Overlapping syndrome of MERRF and MELAS: Molecular and neuroradiological studies
43. The 3243 MELAS mutation in a pedigree with MERRF
44. The A to G transition at nt 3243 of the mitochondrial tRNALeu(UUR) may cause an MERRF syndrome
45. Myo-leukoencephalopathy in twins: Study of 3243-myopathy, encephalopathy, lactic acidosis, and strokelike episodes mitochondrial DNA mutation
46. MELAS: A new disease-associated mitochondrial DNA mutation and evidence for further genetic heterogeneity
47. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS
48. A mitochondrial tRNA(Val) gene mutation (G1642A) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes
49. Random mitotic segregation of mitochondrial DNA in MELAS syndrome
50. Diagnosis of mitochondrial disease: Assessment of mitochondrial DNA heteroplasmy in blood
51. Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone
52. Stroke, hemiparesis and deficient mitochondrial beta-oxidation
53. MELAS syndrome: Peripheral neuropathy and cytochrome c-oxidase deficiency. A case report and review of the literature
54. Mitochondrial myopathy and familial thiamine deficiency
55. Increase of blood NAD+and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome
56. Clinical improvement after administration of coenzyme Q10 in a patient with mitochondrial encephalomyopathy
57. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10
58. Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry
59. Correction of pancreatic beta-cell dysfunction with coenzyme Q(1O) in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome and diabetes mellitus
60. Concomitant administration of sodium dichloroacetate and vitamin B1 for lactic acidemia in children with MELAS syndrome
61. Effects of dichloroacetate in three patients with MELAS